Unknown

Dataset Information

0

Is IL-6 the Right Target in COVID-19 Severe Pneumonia?

ABSTRACT:

SUBMITTER: Blot M 

PROVIDER: S-EPMC7781133 | biostudies-literature | 2021 Jan

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Is IL-6 the Right Target in COVID-19 Severe Pneumonia?

Blot Mathieu M   Bourredjem Abderrahmane A   Binquet Christine C   Piroth Lionel L  

American journal of respiratory and critical care medicine 20210101 1

Similar Datasets

Unknown Tocilizumab for severe COVID-19 pneumonia.
| S-EPMC7431163 | biostudies-literature
Unknown Tocilizumab for severe COVID-19 pneumonia.
| S-EPMC7431124 | biostudies-literature
Unknown [Thrombus in the right atrium after COVID-19 pneumonia].
| S-EPMC7284256 | biostudies-literature
Unknown Thrombus in the right atrium after COVID-19 pneumonia.
| S-EPMC7366995 | biostudies-literature
Unknown Severe Hypoxemia in Early COVID-19 Pneumonia.
| S-EPMC7427389 | biostudies-literature
Unknown Proteomic blood profiling in mild, severe and critical COVID-19 patients
| S-BSST416 | biostudies-other
Unknown Respiratory Impairment Predicts Response to IL-1 and IL-6 Blockade in COVID-19 Patients With Severe Pneumonia and Hyper-Inflammation.
| S-EPMC8117339 | biostudies-literature
Unknown Tocilizumab for severe COVID-19 pneumonia - Authors' reply.
| S-EPMC7431126 | biostudies-literature
Unknown Bronchoalveolar lavage findings in severe COVID-19 pneumonia.
| S-EPMC7225401 | biostudies-literature
Unknown IL-6 modulation for COVID-19: the right patients at the right time?
| S-EPMC8042594 | biostudies-literature